Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-24-047029
Filing Date
2024-11-15
Accepted
2024-11-15 08:04:37
Documents
3
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 6-K ef20038701_6k.htm 6-K 9762
2 EXHIBIT 99.1 ef20038701_ex99-1.htm EX-99.1 17020
3 image00001.jpg GRAPHIC 3177
  Complete submission text file 0001140361-24-047029.txt   32363
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38283 | Film No.: 241465901
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)